Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35
CAD
Market Closed
Market Cap:
CA$15.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
CA |
|
L
|
L'Oreal SA
XETRA:LOR
|
FR |
|
Apple Hospitality REIT Inc
NYSE:APLE
|
US |
|
Hipages Group Holdings Ltd
ASX:HPG
|
AU |
|
M
|
Max India Ltd
NSE:MAXIND
|
IN |
|
Denny's Corp
NASDAQ:DENN
|
US |
|
Wilmar International Ltd
SGX:F34
|
SG |
|
Fifth District Bancorp Inc
NASDAQ:FDSB
|
US |
|
Take And Give Needs Co Ltd
TSE:4331
|
JP |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRV's stock price target?
Not Available
MRV doesn't have any price targets made by Wall Street professionals.
What is Nuvo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%
5%
For the last 8 years the
compound annual growth rate for
Nuvo Pharmaceuticals Inc's revenue is
18%.
The projected
CAGR
for the next 2 years is
5%.
What is Nuvo Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-26%
-26%
The
compound annual growth rate
of Nuvo Pharmaceuticals Inc's operating income for the next 4 years is
-26%.
